Small Cap Hong Kong (HSI) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Aug 22, 2025

Discover small cap Hong Kong Pharmaceuticals & Biotech companies that are on the HSI. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

114 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1889
Sanai Health Industry Group
HK$0.40-8.0%21.2%HK$61.2mn/aPB0.2xn/an/a
8247
Biosino Bio-Technology and Science Incorporation
HK$0.78-17.9%20.0%HK$112.9mn/aPB0.6xn/a0%
1312
Kontafarma China Holdings
HK$0.0310%-6.1%HK$173.2mn/aPB0.2xn/a0%
1498
PuraPharm
HK$0.45-1.1%-32.8%HK$177.8mn/aPB1.6xn/a0%
8225
China Health Group
HK$0.180.6%100.0%HK$179.2mn/aPS6.2xn/an/a
575
Regent Pacific Group
HK$0.860%56.4%HK$251.0mn/aPS44.6xn/an/a
1652
Fusen Pharmaceutical
HK$0.34-2.8%-64.1%HK$255.1mn/aPB0.6xn/a0%
8329
Shenzhen Neptunus Interlong Bio-technique
HK$0.15-3.8%4.1%HK$258.4mn/aPE9.5xn/a3.5%
8158
China Regenerative Medicine International
HK$0.861.2%616.7%HK$261.7mn/aPE14.7xn/an/a
858
Extrawell Pharmaceutical Holdings
HK$0.13-2.3%231.6%HK$301.1mn/aPE1.4xn/an/a
897
Wai Yuen Tong Medicine Holdings
HK$0.32-3.1%57.5%HK$354.4mn/aPE49.9xn/a0%
455
Tianda Pharmaceuticals
HK$0.17-9.0%-22.3%HK$367.7mn/aPS1.1xn/a0%
1011
China NT Pharma Group
HK$0.74-5.1%190.2%HK$498.9mn/aPS24.6xn/a0%
1643
Modern Chinese Medicine Group
HK$0.724.3%114.9%HK$518.4mn/aPE49.2xn/a0%
6118
Austar Lifesciences
HK$1.31-3.0%92.6%HK$671.5mn/aPE38.3xn/a0%
3737
Zhongzhi Pharmaceutical Holdings
HK$0.811.3%-12.0%HK$699.5mn/aPE6.7xn/a6.1%
239
Pak Fah Yeow International
HK$2.40-1.2%3.0%HK$747.9mn/aPE10.5xn/a8.3%
690
Uni-Bio Science Group
HK$0.1610.3%201.9%HK$955.4mn/aPE11.5xn/a1.7%
2898
Sunho Biologics
HK$6.930.4%1.9%HK$1.0bn/aPS25227.6xn/an/a
1228
CANbridge Pharmaceuticals
HK$2.4835.5%904.0%HK$1.1bn/aPS11.4xn/an/a
9939
Kintor Pharmaceutical
HK$2.380.8%155.9%HK$1.1bn/aPS198.8xn/an/a
950
Lee's Pharmaceutical Holdings
HK$1.85-14.0%50.4%HK$1.1bn/aPE11.7xn/a2.7%
2257
Sirnaomics
HK$10.4715.6%310.6%HK$1.1bHK$72.10PS78.6xS48.0%n/a
2496
Wuhan YZY Biopharma
HK$5.701.8%-11.2%HK$1.1bn/aPS9.4xn/an/a
Page 1 of 5